Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Torres

Showing results (21-30 of 274) with videos related to

Pageof 28
Sort By:
Dermatology and Therapy|March 3, 2026
High-Dose, Extended Half-Life IL-23 Inhibitors: the Next Big Step in Psoriasis Care?Tiago Torres, Andrew Blauvelt
American Journal of Clinical Dermatology|March 12, 2026
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of PsoriasisCésar Ferreira, Tiago Torres
The Journal of International Medical Research|June 30, 2023
Difamilast for the treatment of atopic dermatitisEgídio Freitas, Tiago Torres
Dermatology Practical & Conceptual|January 13, 2022
Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and UpadacitinibMiguel Nogueira, Tiago Torres
Journal of the American Academy of Dermatology|May 22, 2019
Reply to: "Comment on 'Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study'"Andrea Chiricozzi, Tiago Torres
Anais Brasileiros De Dermatologia|October 15, 2010
Treatment of hidradenitis suppurativa with infliximabTiago Torres, Manuela Selores
Acta Bio-Medica : Atenei Parmensis|October 1, 2015
Obesity: a key component of psoriasisBernardo Correia, Tiago Torres
Drug Development Research|August 11, 2015
Small Molecules in the Treatment of PsoriasisTiago Torres, Paulo Filipe
Dermatology and Therapy|February 27, 2026
Perspectives and Real-World Clinical Practice of Portuguese Dermatologists on Biologic Dose Spacing in Psoriasis: Results from a Nationwide SurveyCésar Ferreira, Tiago Torres
Acta Medica Portuguesa|May 13, 2014
[Interleukin-17 as a therapeutic target in psoriasis]Tiago Torres, Paulo Filipe
Pageof 28

Showing results (21-30 of 274) with videos related to

Sort By:
Pageof 28
Dermatology and Therapy|March 3, 2026
High-Dose, Extended Half-Life IL-23 Inhibitors: the Next Big Step in Psoriasis Care?Tiago Torres, Andrew Blauvelt
American Journal of Clinical Dermatology|March 12, 2026
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of PsoriasisCésar Ferreira, Tiago Torres
The Journal of International Medical Research|June 30, 2023
Difamilast for the treatment of atopic dermatitisEgídio Freitas, Tiago Torres
Dermatology Practical & Conceptual|January 13, 2022
Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and UpadacitinibMiguel Nogueira, Tiago Torres
Journal of the American Academy of Dermatology|May 22, 2019
Reply to: "Comment on 'Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study'"Andrea Chiricozzi, Tiago Torres
Anais Brasileiros De Dermatologia|October 15, 2010
Treatment of hidradenitis suppurativa with infliximabTiago Torres, Manuela Selores
Acta Bio-Medica : Atenei Parmensis|October 1, 2015
Obesity: a key component of psoriasisBernardo Correia, Tiago Torres
Drug Development Research|August 11, 2015
Small Molecules in the Treatment of PsoriasisTiago Torres, Paulo Filipe
Dermatology and Therapy|February 27, 2026
Perspectives and Real-World Clinical Practice of Portuguese Dermatologists on Biologic Dose Spacing in Psoriasis: Results from a Nationwide SurveyCésar Ferreira, Tiago Torres
Acta Medica Portuguesa|May 13, 2014
[Interleukin-17 as a therapeutic target in psoriasis]Tiago Torres, Paulo Filipe
Pageof 28